Verogalid Er

Verogalide EP: a drug for the treatment of cardiovascular diseases

Verogalide EP (also known by the international name Verapamil) is a calcium channel blocker of the phenylalkylamine group produced by the Czech pharmaceutical group Galena AS. This drug is an effective medicine for the treatment of various cardiovascular diseases.

Verogalide EP is presented in the form of film-coated tablets containing 240 mg of the active substance verapamil. This drug is used to treat the following diseases: paroxysmal supraventricular tachycardia (except WPW syndrome), sinus tachycardia, atrial extrasystole, atrial fibrillation and flutter, angina pectoris (including Prinzmetal, tension, post-infarction), arterial hypertension, hypertensive crisis, idiopathic hypertrophic subaortic stenosis, hypertrophic cardiomyopathy.

However, there are contraindications to the use of Verogalide EP. These are hypersensitivity to the active substance, severe hypotension, cardiogenic shock, AV block II and III degrees, myocardial infarction (acute or recently suffered and complicated by bradycardia, hypotension, left ventricular failure), chronic heart failure stage III, WPW syndrome and sick sinus syndrome. node (if a pacemaker is not implanted), sinoatrial block, Morgagni-Adams-Stokes syndrome, digitalis intoxication, severe stenosis of the aortic mouth, pregnancy, breastfeeding. There are also restrictions on the use of Verogalid EP, such as AV block of the first degree, chronic heart failure stages I and II, severe bradycardia (less than 50 beats/min), mild or moderate hypotension, severe myopathy (Duchenne syndrome), liver dysfunction or kidneys, ventricular tachycardia with a wide QRS complex (for intravenous administration).

When using Verogalid EP, side effects may occur from the cardiovascular system and blood (hypotension, bradycardia (sinus), AV block, heart failure), from the nervous system and sensory organs (headache, dizziness, drowsiness, visual impairment), from the digestive system (nausea, constipation, diarrhea, dyspepsia), as well as allergic reactions (skin rash, itching, urticaria, angioedema). If any side effects occur, you should consult your doctor.

The dosage of Verogalid EP should be individual and determined depending on the severity of the disease, age and condition of the patient. Usually the initial dose is 80-120 mg 2-3 times a day, if necessary the dose can be gradually increased to a maximum dose of 480 mg per day.

In conclusion, Verogalid EP is an effective drug for the treatment of various cardiovascular diseases, but its use should only be carried out as prescribed by a doctor and in compliance with all contraindications and restrictions.